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Summary
X-linked congenital stationary night blindness (CSNB)
is a nonprogressive retinal disorder characterized by dis-
turbed or absent night vision; its clinical features may
also include myopia, nystagmus, and impaired visual
acuity. X-linked CSNB is clinically heterogeneous, and
it may also be genetically heterogeneous. We have stud-
ied 32 families with X-linked CSNB, including 11 fam-
ilies with the complete form of CSNB and 21 families
with the incomplete form of CSNB, to identify genetic-
recombination events that would refine the location of
the disease genes. Critical recombination events in the
set of families with complete CSNB have localized a
disease gene to the region between DXS556 and
DXS8083, in Xp11.4-p11.3. Critical recombination
events in the set of families with incomplete CSNB have
localized a disease gene to the region between DXS722
and DXS8023, in Xp11.23. Further analysis of the in-
complete-CSNB families, by means of disease-associ-
ated–haplotype construction, identified 17 families, of
apparent Mennonite ancestry, that share portions of an
ancestral chromosome. Results of this analysis refined
the location of the gene for incomplete CSNB to the
region between DXS722 and DXS255, a distance of 1.2
Mb. Genetic and clinical analyses of this set of 32 fam-
ilies with X-linked CSNB, together with the family stud-
ies reported in the literature, strongly suggest that two
loci, one for complete (CSNB1) and one for incomplete
(CSNB2) X-linked CSNB, can account for all reported
mapping information.
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Introduction
X-linked congenital stationary night blindness (CSNB)
is a nonprogressive retinal disorder; its clinical features
include impaired night vision, variable myopia, reduced
visual acuity, and congenital nystagmus (Carr 1974; Krill
1977; Khouri et al. 1988; Pearce et al. 1990; He´on and
Musarella 1994; Miyake et al. 1994). Clinical hetero-
geneity among families with CSNB has led to the sug-
gestion that the X-linked variety of CSNB should be
classified as either complete (CSNB1 [MIM 310500]) or
incomplete (CSNB2 [MIM 300071]) (Miyake et al.
1986). This classification is based on abnormalities both
in the electroretinogram (ERG) (e.g., the scotopic b wave
and the oscillatory potentials) and in the psychophysical
dark-adaptation thresholds. In the complete form of
CSNB, both the scotopic b wave that is evoked by dim
blue flashes and the early oscillatory-potential wavelets
are nonrecordable, and the night blindness is profound,
as documented by the lack of rod adaptation to dark-
ness. In the incomplete form of CSNB, the scotopic b
wave is recordable, although it is subnormal in ampli-
tude; the scotopic oscillatory potentials are often re-
cordable, but they may show abnormal implicit times;
and the psychophysical dark-adaptation thresholds are
only slightly elevated above normal (for a review, see
He´on and Musarella 1994).
Since the original localization of X-linked CSNB to
Xp11, by linkage analysis (Gal et al. 1989; Musarella
et al. 1989; Bech-Hansen et al. 1990), there has been
uncertainty about whether the mapping information for
X-linked–CSNB families supports genetic heterogeneity
or whether it supports, instead, a single locus that ex-
hibits wide variation in clinical phenotype (Khouri et al.
1988; Pearce et al. 1990). Early studies that used linkage
and multipoint analyses of complete-CSNB and incom-
plete-CSNB families mapped these conditions to the
same region (Musarella et al. 1992). Furthermore, re-
combinant chromosomes in families that have been ex-
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amined to date have provided location information for
X-linked CSNB, but seldom have individual families
provided both close proximal and distal limits for a min-
imal genetic region that contains the disease gene. Data
from the few families that are highly informative indicate
that a minimum of two loci for X-linked CSNB are pos-
sible: one proximal to DXS426 (Bech-Hansen et al.
1991) and one in the region distal to DXS1003-TIMP1-
DXS426 (Musarella et al. 1989; Aldred et al. 1992; Ber-
ger et al. 1995) or DXS228 (Bergen et al. 1995).
In addition to use of recent crossover events to localize
a disease gene, ancestral crossovers can be investigated
by disease-associated haplotype mapping in isolated
populations. The assumption is that a distinct haplotype
that reflects the specific allele combination of the an-
cestral chromosome should be present, in the immediate
vicinity of a disease gene, in the descendants (for a re-
view, see de la Chapelle 1993). Such studies have refined
the location of several disease genes, including that for
cystic fibrosis (Kerem et al. 1989); the cystic fibrosis gene
is one of the first to be isolated by means of a positional
cloning strategy.
To resolve the question of genetic heterogeneity in X-
linked CSNB, we characterized 25 crossover events that
were identified in 32 families affected by either the com-
plete or the incomplete form of the disease. In addition,
disease-associated–haplotype analysis identified a subset
of families, of apparent Mennonite ancestry, with in-
complete X-linked CSNB. These families possess a com-
mon haplotype that provides additional information on
the location of the gene for incomplete CSNB. We pres-
ent these data in the context of information published
elsewhere, and we propose that two loci in Xp11 can
account for the current mapping information on X-
linked CSNB.
Subjects and Methods
Families
Thirty-two families that segregate X-linked CSNB
were ascertained from a number of ophthalmologic cen-
ters in Canada, Japan, and the United States. Members
of each family included in the present study underwent
ophthalmologic examination and diagnosis according to
procedures outlined elsewhere (Miyake et al. 1986;
Khouri et al. 1988; Musarella et al. 1989; Pearce et al.
1990; Ruttum et al. 1992; Bech-Hansen and Pearce
1993). Family structure and clinical findings for 14 of
the 32 families have been reported elsewhere; they in-
clude families 50(B), 70(A), 80(I), and 100(D) (Pearce
et al. 1990); family 60(C) (Pearce et al. 1990; Bech-
Hansen and Pearce 1993); families 9, R005, R007,
Y001, Y002, and Y003 (Musarella et al. 1989); family
21 (Khouri et al. 1988; Musarella et al. 1989); and fam-
ily 260 (Ruttum et al. 1992).
Of the 32 families, 11 (families 9, 260, 270, B1, B2,
R005, R006, R007, Y001, Y002, and Y003) had absent
rod scotopic vision, as determined from ERGs generated
in response to a dim blue flash; absent oscillatory-po-
tential wavelets; and/or profound night blindness (the
absence of the rod branch in the dark-adaptation curve);
these features are consistent with the complete form of
X-linked CSNB. The remaining 21 families (21, 50, 60,
60B, 70, 80, 100, 130, 140, 150, 160, 170, 180, 190,
200, 230, 240, 250, 330, 340, and M10) had reduced
but not absent rod scotopic vision, determined by means
of ERG generated with a dim blue flash, and/or at least
one member from each family had reduced but not ab-
sent rod psychophysical dark-adaptation findings; these
characteristics were compatible with the incomplete
form of the disease.
Families 21 and 60 were initially reported to contain
both complete-CSNB and incomplete-CSNB patients.
One of the four affected males in the family reported by
Khouri et al. (1988) (designated “21” in the report by
Musarella et al. [1989]) had both myopia and a relative
lack of oscillatory potentials, consistent with complete
CSNB, and two of nine affected males in a family re-
ported by Pearce et al. (1990) (“family C”; referred to
as “family 60” in the present report) had a dark-ad-
aptation reduction that was severe enough to be con-
sidered an indication of complete CSNB, in accordance
with the original definition (Miyake et al. 1986). These
two families are included here as having incomplete
CSNB, on the basis of both reevaluation of data (Miyake
1989; Weleber et al. 1989) and further clinical analyses
(Bech-Hansen et al., in press).
Marker Analysis
Informed consent was obtained and blood was col-
lected from family members. DNA was extracted, and
RFLP and microsatellite polymorphism analyses were
performed as described elsewhere (Musarella et al. 1989;
Bech-Hansen et al. 1990; Bech-Hansen and Pearce
1993). Details on the RFLP (TIMP1) and the VNTR
(DXS255) analyses used in this study can be found else-
where (Musarella et al. 1989; Bech-Hansen and Pearce
1993). The microsatellite polymorphisms used in the
present study include DXS8026, DXS556, DXS1368,
DXS993, DXS228, DXS6810, DXS7, MAOA, MAOB,
and DXS8083 (redesigned primers are L, 5′-CTT CTG
CAC AGC AAA GGA AA; and R, 5′-ACT CCA GGA
GGC CGT ATG TC); EC8058 (DXS9931); DXS1055,
DXS1003, SYN1, and DXS426 (Boycott et al. 1997);
DXS6849 (Boycott et al. 1997); DXS722 (Boycott et al.
1996); DXS6940, DXS1126, DXS1240, and DXS1470
(Boycott et al. 1997); DXS573, DXS8023, DXS1000,
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Figure 1 Fifteen recombination events in X chromosomes from nine families that segregate the complete form of X-linked CSNB.
Polymorphic marker loci are shown on the far left, and the family and individual designations are shown along the top of the panel. The status
of the person carrying the depicted chromosome is also indicated, along the top: AF  affected female; AM  affected male; CF  carrier
female; and UM  unaffected male. Blackened circles indicate the loci that are in phase with the disease gene, unblackened circles indicate the
loci that are out of phase, and short horizontal lines indicate uninformative markers. The downward-pointing arrow indicates the location of
the disease gene in a family in which only one crossover has been identified, and brackets indicate the locations of the disease genes in families
in which two crossovers or double crossovers have been identified that give both the distal and proximal limits of the disease gene.
DXS988, and DXS991; and the relevant information can
be found in the Human Genome Database (GDB), unless
stated otherwise. The allele sizes that we detected for
the microsatellites DXS6940 (163–167 bp) and
DXS1126 (239–261 bp) were slightly outside the range
reported in the GDB. The map order of all the markers
either was based on the X-chromosome consensus map
(Nelson et al. 1995) or was determined by use of a panel
of somatic-cell hybrids (Boycott et al. 1997) and detailed
YAC contigs (Boycott et al. 1996; K. Stoddart and N.T.
Bech-Hansen, unpublished data) within the region.
Results
Evaluation of Recombinant Chromosomes in X-Linked
CSNB Families
Thirty-two families with X-linked CSNB were as-
sessed for crossovers, on the X chromosome, that would
localize the segregating disease gene. Crossovers iden-
tified in six complete-CSNB families (Musarella et al.
1989) and in three incomplete-CSNB families had been
reported elsewhere (Musarella et al. 1989; Bech-Hansen
et al. 1992; Bech-Hansen and Pearce 1993).
Complete X-linked CSNB.—Of the 11 families with
complete CSNB, 6 had been reported to have crossovers
in Xp11 (Musarella et al. 1989): In family 9, the disease
gene was localized proximal to OTC; in family R005,
between DXS206 and TIMP1; in family R007, between
DXS206 and TIMP1; in family Y001, between OTC and
DXS255; in family Y002, between DXS206 and TIMP1;
and, in family Y003, between OTC and DXS255. To
further refine the position of the gene for complete CSNB
(designated “CSNB1”), we investigated the recombinant
chromosomes in these families, using new microsatellite
markers, and we identified and investigated crossovers
in five new complete-CSNB families.
Results of these analyses are presented in figure 1.
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Figure 2 Eleven recombination events in X chromosomes from seven families that segregate the incomplete form of X-linked CSNB.
Symbols are as described in legend to figure 1.
Informative crossovers were identified in three of the five
new families: In family B2, one individual carried a dou-
ble-recombinant chromosome that localized the CSNB1
gene to the region between DXS84 and TIMP1; in family
B1, two recombinant chromosomes were identified that
placed the CSNB1 gene in the region between DXS556
and DXS8083; and, in family R006, crossovers placed
the CSNB1 gene between DXS556 and DXS255. In four
of the six families reported elsewhere, the location of
the CSNB1 gene was refined (fig. 1): In family Y002,
the location of the gene was refined to the interval be-
tween DXS206 and DXS8083; in family Y001, to the
region between DXS556 and DXS1003; in family Y003,
to the region between DXS556 and EC8058; and, in
family R007, to the region between DXS206 to
DXS1055. In summary, the location of the gene for
CSNB1, between the markers DXS556 and DXS8083
(the distal and proximal limits defined by family B1), is
consistent with all the recombinant-chromosome map-
ping information for our set of 11 families with complete
CSNB.
Incomplete X-linked CSNB.—Of the 21 incomplete-
CSNB families, 4 (families 60, 60B, 70, and 21) had
been reported to have crossovers that sublocalized the
gene for incomplete CSNB (designated “CSNB2”) on
the X chromosome. An affected female in family 60
carried a recombinant chromosome that successively po-
sitioned the CSNB2 gene proximal to TIMP1 (Bech-
Hansen and Pearce 1993), DXS426 (Bech-Hansen et al.
1991), and DXS6849 (Bech-Hansen et al., in press). This
female is believed to have incomplete CSNB, because she
has inherited two copies of the same mutant CSNB2
gene—one from her father (a member of family 60) and
the other from her mother (a member of family 60B).
Although there is no known common ancestor, there is
evidence for homozygosity by descent (Bech-Hansen and
Pearce 1993; Bech-Hansen et al., in press). Other cross-
overs identified in family 60 have mapped the CSNB2
gene distal to DXS988 (Boycott et al. 1994) and
DXS8023 (Bech-Hansen et al., in press). In addition,
clinical and genetic analysis of the extended family (60B)
has been performed, and the CSNB2 gene in this family
has been mapped to the region between DXS1003 and
DXS991 (Bech-Hansen et al., in press). Furthermore, an
individual from family 70 was reported to carry a re-
combinant chromosome that placed the CSNB2 gene
proximal to DXS7 (Bech-Hansen et al. 1992), whereas
an individual from family 21 was reported to carry a
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Table 1
Haplotype Analysis of 17 Families with Incomplete X-Linked CSNB
FAMILY/
FAMILIES
LOCUS
MAOB
DXS
8083
PEC
8058
DXS
1055
DXS
1003 SYN1
DXS
426
DXS
6849
DXS
722
DXS
6940
DXS
1126
DXS
1240
DXS
1470
DXS
573
DXS
1039
DXS
255
DXS
8023
150, 160,
180, 20 184 240 313 87 181 195
220
245 190 163 257 169 206 139 93 D 132
340 184 240 313 87 181 195 222 245 190 163 257 169 206 139 93 D 132
190 178 240 313 87 181 195 220 245 190 163 257 169 206 139 93 D 132
250 176 240 313 87 181 195 220 245 190 163 257 169 206 139 93 D 132
170 180 232 313 87 181 195 220 245 190 163 257 169 206 139 93 D 132
130a 180 232 317 87 181 195 220 245 190 163 257 169 206 139 93 D 132
200 180 244 315 87 181 195 220 245 190 163 257 169 206 139 93 D 132
60Ba 174 232 315 93 185 195 220 245 190 163 257 169 206 130 93 D 132
80 182 232 313 87 191 195 220 245 190 163 257 169 206 139 93 D 132
21 178 238 313 91 185 203 220 245 190 163 257 169 206 139 93 C 144
50 176 244 317 93 187 195 222 245 190 163 257 169 206 139 93 D 132
330 182 232 315 91 187 197 222 245 190 163 257 169 206 139 93 D 132
60-Pa 182 230 317 95 187 205 222 239 190 163 257 169 206 139 93 D 140
70a 170 242 317 83 183 203 226 239 190 163 257 169 208 139 93 D 132
60-Da 174 232 315 93 185 203 240 241 192 163 257 169 206 139 93 D 132
NOTE.—Lines in the table delineate the portion of the haplotypes shared between families.
a Haplotype is from a recombinant individual.
recombinant chromosome that placed the CSNB2 gene
proximal to DXS84 (Musarella et al. 1989). To further
refine the map position of CSNB2, we continued to in-
vestigate the recombinant chromosomes in these fami-
lies, using new microsatellite markers, and we identified
and investigated crossovers in 16 new incomplete-CSNB
families.
Results of these analyses are presented in figure 2.
Crossovers were identified in 3 of the 16 new families:
In family M10, a crossover in an affected male placed
the CSNB2 gene proximal to MAOA, and, in families
130 and 140, crossovers placed the gene proximal to
MAOB and distal to DXS988. In two of the three fam-
ilies reported elsewhere, the location of the CSNB2 gene
was refined (fig. 2): In family 70, the location of the
CSNB2 gene was refined to the region proximal to
MAOB, and, in family 60, the location of the CSNB2
gene was refined to the interval between DXS722 and
DXS8023. In summary, the location of the gene for
CSNB2, between the markers DXS722 and DXS8023
(the distal and proximal limits of the gene, in family
60), is consistent with all the recombinant-chromo-
some–mapping information for our set of 21 incomplete-
CSNB families.
Of the 21 families with incomplete X-linked CSNB,
the majority did not contain any crossovers that would
help to localize the CSNB2 gene. Eighteen of the 21
families were from Alberta, and 4 of these were known
to be of Mennonite ancestry. To determine whether the
apparent high incidence of incomplete CSNB in Alberta
was due to an ascertainment bias or to a common-
ancestor effect, we performed disease-associated–
haplotype analysis.
Haplotype Analysis
Identification of disease-associated haplotypes pro-
vides a powerful approach for localization of a disease
gene, in relation to DNA markers, and for identification
of descendants of a founder population. Using 24 DNA
markers that span most of Xp11, we constructed hap-
lotypes for one affected male from each incomplete-
CSNB family. Recombinant chromosomes that resulted
from crossovers between any of the markers tested were
included in the haplotype analysis. Specifically, in family
60, chromosomes recombinant for the markers used in
haplotype construction are carried by an affected male
and an affected female (60P and 60D, respectively), so
both of these recombinant chromosomes were included
in the analysis. Of the 21 families with incomplete
CSNB, 17 retained various portions of a common hap-
lotype that spans the region between marker DXS8026
and the centromere; haplotypes that span the region be-
tween the markers MAOB and DXS8023 are shown in
table 1. These haplotypes suggest that 85% of the dis-
ease-associated chromosomes in our incomplete-CSNB
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families are separated by single recombination events
from a putative ancestral founding-mutation haplotype
that spans the proximal portion of Xp11. Greater de-
partures from the ancestral haplotype were seen with the
distal set of DNA markers.
Although no new distal-limit information on the lo-
cation of the CSNB2 gene was gained (it remains at
DXS722), the affected haplotype of family 21 potentially
moves the proximal limit of this gene from DXS8023
to DXS255. All 17 families, with the exceptions of fam-
ilies 70 and 340, share the entire haplotype between the
markers DXS722 and DXS255. The haplotypes in fam-
ilies 70 and 340 deviate from the common haplotype,
at markers DXS1470 and DXS426, respectively; this is
probably due to a recent spontaneous mutation at this
locus, which is not unexpected at a dinucleotide-repeat
marker (Weber 1990).
Of the 17 families that share the common haplotype,
4 are of known Mennonite ancestry. Further investiga-
tion of the genealogies of the other 13 families suggested
that they are all of Mennonite ancestry. Isolated popu-
lations, such as the Mennonites, can potentially have
allele frequencies that are significantly different from
those of the general Caucasian population. Therefore,
the allele frequencies of all markers within the common
haplotype were determined for a set of 31 Mennonites,
chosen at random. Our results indicate that the allele
frequencies in the Mennonite population are not signif-
icantly different from the allele frequencies in the Cau-
casians reported in the GDB, for any of the markers
(data not shown). Therefore, the common Mennonite
haplotype that contains the CSNB2 gene is apparently
not the result of preferentially high frequencies of this
set of alleles in the Mennonite population studied. This
haplotype information, combined with the crossover in
family 60 that defined the distal limit, suggests that the
CSNB2 gene is located in the region between DXS722
and DXS255.
Discussion
Eleven complete-CSNB and 21 incomplete-CSNB
families were studied, to refine the location of the locus
or loci responsible for these two entities and, in turn, to
evaluate the role of genetic heterogeneity in X-linked
CSNB. In summary, our findings establish separate loci
for the two forms of X-linked CSNB. The crossovers
that we observed in family B1 and family 60 currently
provide the most refined localizations, within individual
families, for the CSNB1 and CSNB2 loci. Our data in-
dicate that a gene (CSNB1) that is responsible for the
complete form of X-linked CSNB lies between the mark-
ers DXS556 and DXS8083 (family B1), in Xp11.4-
p11.3. This finding is entirely consistent with the map-
ping information that we have presented for the other
complete-CSNB families. The results of our crossover-
mapping studies also indicate that a gene (CSNB2) that
is responsible for the incomplete form of X-linked CSNB
lies between the markers DXS722 and DXS8023 (family
60), in Xp11.23. This finding is also consistent with the
recombination-based mapping information that we have
presented for the other incomplete-CSNB families.
To put published clinical and recombination data in
the context of findings presented in this report, we iden-
tified individuals, in eight families reported by other lab-
oratories, who carry recombinant chromosomes (fig. 3).
Except for two instances, the published crossovers were
not accompanied by sufficient clinical information to
establish clearly whether the individual families were
segregating the complete or the incomplete form of X-
linked CSNB.
Of the two families for which sufficient clinical in-
formation was available, one family could be classified
as having complete X-linked CSNB (Gal et al. 1989),
and the other could be classified as having incomplete
X-linked CSNB (Bergen et al. 1994) (see fig. 3). In the
complete-CSNB family, two recombinant chromosomes
localized a CSNB gene distal to TIMP1 (Gal et al. 1989;
Li et al. 1991), whereas, in the incomplete-CSNB family,
one recombinant chromosome localized a CSNB gene
proximal to MAOB (Bergen et al. 1994). This mapping
information is consistent with the two-locus hypothesis
that we have presented here.
The clinical findings reported for the remaining six
families precluded classification on the basis of complete
or incomplete CSNB. In the initial report on the mapping
of X-linked CSNB, Gal et al. (1989) observed crossovers
that, in their family 2, placed the CSNB gene distal to
DXS255 and that, in their family 3, placed the CSNB
gene distal to the region between OTC and DXS255.
The mapping information for these two families overlaps
with the proposed minimal regions for both the CSNB1
and the CSNB2 genes. In two other families (families 3
and 4; Aldred et al. 1992), crossovers localized the CSNB
gene to the region proximal to DMD, again overlapping
with proposed minimal regions for both the CSNB1 and
the CSNB2 genes. Reported crossovers in a Dutch family
localized the CSNB gene to the region between OTC
and DXS1003 (Berger et al. 1995); this finding is con-
sistent with segregation of the CSNB1 gene in this family.
An affected male in another Dutch CSNB family (Bergen
et al. 1995) carried a double-recombinant chromosome
that localized the CSNB gene to the region between
DMD44 and DXS228, which again overlaps with the
CSNB1 minimal region. If this proves to be a family
with complete CSNB, then the minimal region for the
CSNB1 gene would be refined to the interval between
DXS556 and DXS228, in Xp11.4.
In the present study, the paucity of critical crossovers
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Figure 3 Recombination-based localization of genetic eye disease genes in Xp11. Part of the X chromosome is represented by the thicker
line, on the left of the figure, and the polymorphic markers are indicated along its left side. In the X-linked CSNB portion of the figure, the
vertical lines delineate minimal regions, determined on the basis of crossover information for complete-CSNB families (thinner line), for
incomplete-CSNB families (thicker line), and for several CSNB families that could not be classified as having the complete or the incomplete
form of CSNB (broken horizontal lines). Immediately to the right of X chromosome line, minimal regions for the CSNB1 and CSNB2 loci are
shown; these were determined on the basis of findings, for two families, that gave the finest localization of the complete (family B1) and the
incomplete (family 60) X-linked CSNB genes. The region spanned by the common Mennonite haplotype is also indicated. Eight recombinant
chromosomes from previously reported CSNB families are also shown; one family (P520) is known to have complete CSNB, one is known to
have incomplete CSNB, and five others are of unknown status (broken vertical lines). An arrow indicates where the distal or proximal limit of
the CSNB gene in that family was not established, and the lines are drawn to the most distal or proximal marker tested. The current minimal
regions for the CSNB1 and CSNB2 loci are represented on the extreme left side of the figure. Previously published recombination-based mapping
information on other X-linked retinal disorders—AIED, RP2, RP3, and COD1—appears in the right portion of the diagram. Numbers in square
brackets, above the vertical lines that represent the minimal regions, refer to specific family studies: [1]  Li et al. (1991); [2]  Bergen et al.
(1994); [3]  Gal et al. (1989); [4]  Aldred et al. (1992); [5]  Bergen et al. (1995); [6]  Berger et al. (1995); [7]  Alitalo et al. (1991);
[8]  Schwartz and Rosenberg (1991); [9]  Glass et al. (1993); [10]  Meindl et al. (1996); [11]  Thiselton et al. (1996); [12]  Bergen
et al. (1993); and [13]  Hong et al. (1994).
in the smaller incomplete-CSNB families prompted us
to attempt to refine the location of the CSNB2 gene, by
determination of the ancestral relationship among these
families, by means of disease-associated–haplotype anal-
ysis. Results of this analysis suggest that most of the
chromosomes in our set of incomplete-CSNB families
were derived from a single founder chromosome (table
1). Derivatives of this haplotype were found in 17 of the
21 incomplete-CSNB families, and the portion of the
retained haplotype varied, from the entire region tested
(DXS8026–DXS991), a distance of 30 cM, to the region
between DXS722 and DXS255, a distance estimated to
be !1 cM (NIH/CEPH Collaborative Mapping Group
1992; Buetow et al. 1994; Gyapay et al. 1994; Matise
et al. 1994; GDB).
A review of the genealogies of all the incomplete-
CSNB families that share the common haplotype sug-
gests that they all have Mennonite ancestry. Between
1874 and 1880, almost 7,000 Mennonites immigrated
to Manitoba from Russia (Epp 1974). Some descendents
of these immigrants are found in Alberta, where mem-
bers of many of the families reported here still reside.
Investigation has so far failed to find a common ancestor
among any of these families; this raises the possibility
that more than one member of the initial immigrant
population had incomplete CSNB. Consequently, it is
likely that some descendants of the Anabaptist move-
ment and members of the Mennonite community, in
Russia and in other parts of the world, are also affected
with incomplete CSNB.
Of the 21 families with incomplete CSNB, 4 do not
share the common haplotype, nor do they share a com-
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mon haplotype with each other. This would suggest that
there are as many as five independent mutations that
cause incomplete X-linked CSNB in our set of families:
the mutation associated with the common Mennonite
haplotype and four other mutations, one each associated
with families 100, 140, 230, and M10. Family M10 is
of Japanese origin, but detailed ancestry data for families
100, 140, and 230 are not available.
Both the genetic and the clinical information presented
in figure 3 are consistent with two loci for X-linked
CSNB: one (CSNB1) for the complete form, in Xp11.4-
p11.3, and one (CSNB2) for the incomplete form, in
Xp11.23. Earlier reports suggested, on the basis of two
families reported to contain both complete-CSNB and
incomplete-CSNB patients (Khouri et al. 1988; Pearce
et al. 1990), that X-linked CSNB is a single disease entity,
with highly variable clinical expression (Pearce et al.
1990). This raises important points regarding the clinical
assessment of CSNB patients. In particular, if testing cri-
teria include only measurement of adaptation to dark-
ness, and if test results for the first individual in each
family show absence of rod adaptation and indicate that
the patient has CSNB, no distinction between the in-
complete and the complete forms of X-linked CSNB is
possible. Ideally, this distinction requires the results of
a scotopic ERG, generated with a dim blue flash. Alter-
natively, it may be possible, by examination of several
patients in the same family by means of measurement
of adaptation to darkness, to observe, in all patients,
either complete loss of rod function, which is associated
with a diagnosis of complete CSNB, or variability in rod
function, which is associated with incomplete CSNB.
The two types of X-linked CSNB also appear to be
nonallelic, since the fundamental defect appears to be
different, based on different ERG responses. In patients
with complete CSNB, the rod b wave is not detectable
by means of scotopic dim blue–flash stimulus, and the
photopic “on” response (b wave) is significantly re-
duced; these features suggest a defect, within the middle
retinal layer, that may prevent the rod signal from reach-
ing the bipolar cells (Carr et al. 1966; Miyake et al. 1987,
1994; Young 1991). In contrast, patients with incom-
plete CSNB show variably but significantly reduced b
waves, in response to scotopic dim blue–flash stimulus,
and significantly reduced “off” and “on” responses to
photopic testing (Miyake et al. 1987, 1994). Therefore,
the pathophysiology that underlies incomplete CSNB in-
cludes both rod and cone disturbances; these distur-
bances may involve structures that are responsible for
building the b wave (Tremblay et al. 1994).
It has been suggested elsewhere that the condition
known as “A˚land Island eye disease” (AIED) is clinically
indistinguishable from incomplete CSNB (Krill 1977;
Musarella et al. 1989; Weleber et al. 1989). Studies of
three AIED families (Alitalo et al. 1991; Schwartz and
Rosenberg 1991; Glass et al. 1993) defined recombinant
chromosomes that together localized the AIED gene be-
tween DXS7 and DXS255, a region that overlaps with
the minimal region for the CSNB2 gene (fig. 3). This
lends further support to the notion that these conditions
are most likely allelic.
Other retinal disorders also map to Xp11. Combined
mapping information for two families with X-linked
cone dystrophy (COD1) localized a gene for COD1, be-
tween DXS84 and SYN1/ARAF1 (Bergen et al. 1993;
Hong et al. 1994). Two genes (RP2 and RP3) that are
responsible for X-linked retinitis pigmentosa (RP) also
map to Xp21.1-p11. Night blindness is a well-known
early-onset symptom of RP, a set of degenerative retinal
diseases that are characterized by progressive concentric
field loss, pigmentary retinopathy, and reduced ERG am-
plitudes. Autosomal forms of CSNB and RP have been
shown to be caused by different mutations in the rho-
dopsin gene, on chromosome 3q (Dryja et al. 1993; Rao
et al. 1994), and in the gene that encodes the b subunit
of the rod cGMP phosphodiesterase, on chromosome 4p
(Gal et al. 1994). In light of these findings, it has been
speculated that the genes responsible for X-linked CSNB
may be allelic with the RP2 or RP3 genes. RP2 was
recently sublocalized to the region between DXS8083
and DXS6616, on the basis of recombinant chromo-
somes from two families with this condition (Thiselton
et al. 1996) (fig. 3). Our mapping information localizes
the gene for incomplete CSNB proximal to
DXS6616—namely, at DXS722; this finding shows that
these two genes are not allelic. A gene for RP3 (RPGR)
was recently cloned, and it maps just distal to OTC, in
Xp21.1 (Meindl et al. 1996; Roepman et al. 1996) (fig.
3). Our mapping information localizes the complete-
CSNB gene as proximal to OTC; this finding shows that
complete CSNB and RP3 are also not allelic. Although
neither RP2 and incomplete CSNB nor RP3 and com-
plete CSNB are allelic, a mutation in the RPGR gene
appears to be responsible for CSNB in at least one family
(Herrmann et al. 1996). As in the autosomal forms of
RP and CSNB, it is possible that a few families with X-
linked CSNB have disease-causing mutations in RP2 or
RP3. Further analysis is required to determine whether
this is indeed the case.
Finally, we would like to address the issue of nomen-
clature for X-linked CSNB. Musarella et al. (1989) orig-
inally used “CSNB1” to designate the locus that seg-
regates in their group of complete-CSNB families. The
work that we have presented, together with published
information, defines a locus for the complete form of X-
linked CSNB, in Xp11.4, between the markers DXS556
and DXS228. We propose that this locus should con-
tinue to be known as “CSNB1.” The use of the abbre-
viation “CSNB1,” in previous publications (Bech-Han-
sen et al. 1990, 1991, 1992; Bech-Hansen and Pearce
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1993) from the laboratory of N.T.B.-H., referred, in each
case, to the X-linked form of CSNB rather than to the
complete-CSNB or incomplete-CSNB clinical status of
the family reported.
Furthermore, “CSNB2” has been used to designate
the locus that segregates in families with incomplete X-
linked CSNB (Musarella et al. 1992; Bergen et al. 1994).
The data that we have presented here define a locus for
the incomplete form of X-linked CSNB, in Xp11.23,
between the markers DXS722 and DXS255. We propose
that this locus should continue to be referred to as
“CSNB2.” The region that contains the CSNB2 gene is
1.2 Mb in size (Boycott et al. 1996; Schindelhauer et al.
1996), and this region can now be targeted for transcript
identification by one or more of the many techniques
available to positional cloners. Identification of the
CSNB1 and CSNB2 genes will ultimately resolve the
uncertainty that surrounds the clinical and genetic het-
erogeneity of X-linked CSNB; it will also provide in-
formation about the basic defects in this X-linked retinal
condition, which, for years, has intrigued and puzzled
investigators.
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